Board Member
Sarepta Therapeutics, Inc. (SRPT)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Michael Severino, M.D. is recorded as CEO and Board Member at Sarepta Therapeutics, Inc. (SRPT). Sarepta Therapeutics, Inc. reported in an 8-K filed July 27, 2026 that Michael Severino, M.D. was appointed Class I director, effective July 28, 2026. Sarepta Therapeutics, Inc. reported in an 8-K filed July 27, 2026 that Michael Severino, M.D. was appointed Chief Executive Officer, effective July 28, 2026. Michael Severino, M.D. has spoken on 1 earnings call and 1 other investor event across 1 company, most recently for Sarepta Therapeutics, Inc. on September 14, 2026.
“Also on July 23, 2026, the Board appointed Dr. Severino, effective as of the Effective Date, as a Class I director, to serve until the Company's 2028 annual meeting of stockholders.”
“On July 23, 2026, the Board of Directors (the "Board") of Sarepta Therapeutics, Inc. (the "Company") appointed Michael Severino, M.D. as Chief Executive Officer of the Company, effective July 28, 2026 (the "Effective Date").”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
2026-07-28–present
2026-07-28–present
Recorded roles and call appearances connecting this person to public companies.
CEO, Board Member
2026-07-28–present
Other people whose current roles at this company are on record from its filings.
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
